Samudio Ruiz et al. found that the presence of a large amount of epidermal growth factor receptor (EGFR) activators in the ascites of ovarian cancer leaded to sustained overexpression of EGFR and its ligands in the tumor microenvironment. The gene discussed is EGFR; the disease is neoplasm.